Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(changed margins to give hallmark sections more room)
Line 9: Line 9:
}}
}}
-
<div style="float:left; width:68%"> <!-- This width add to the the margin below to equal 99%-->
+
<div style="float:left; width:73%"> <!-- This width add to the the margin below to equal 99%-->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
Line 23: Line 23:
</div>
</div>
-
<div style="float:right; width:31%"> <!-- This margin should be right of the above -->
+
<div style="float:right; width:26%"> <!-- This margin should be right of the above -->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal

Revision as of 21:23, 4 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Translation inhibitors in chronically activated PDGFRA cells (Homo sapiens)

Image does not exist
Translation inhibitors in chronically activated PDGFRA cells
Evading growth suppressors

Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer (Homo sapiens)

Image does not exist
Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer
Activating invasion and metastasis

Focal adhesion: PI3K-Akt-mTOR-signaling (Homo sapiens)

Image does not exist
Focal adhesion: PI3K-Akt-mTOR-signaling
Enabling replicative immortality

Wnt signaling (Homo sapiens)

Image does not exist
Wnt signaling
Inducing angiogenesis

VEGFA-VEGFR2 signaling (Homo sapiens)

Image does not exist
VEGFA-VEGFR2 signaling
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

Glycolysis and gluconeogenesis (Homo sapiens)

Image does not exist
Glycolysis and gluconeogenesis
Genome instability and mutation

One-carbon metabolism (Homo sapiens)

Image does not exist
One-carbon metabolism
Tumor promoting inflammation

Chemokine signaling (Homo sapiens)

Image does not exist
Chemokine signaling
Avoiding immune destruction

Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens)

Image does not exist
Altered glycosylation of MUC1 in tumor microenvironment
Therapeutics

Cancer immunotherapy by PD-1 blockade (Homo sapiens)

Image does not exist
Cancer immunotherapy by PD-1 blockade

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools